Clinical trial shows efficacy and safety of brepocitinib for treating adults with psoriatic arthritis
Brepocitinib is an oral drug that inhibits certain enzymes involved in inflammation-;called tyrosine kinase 2 and Janus kinase 1-;and is being tested for the treatment of several immunological diseases.